Your shopping cart is currently empty

N-Phenylthiourea (Phenylthiocarbamide) is a phenyl ring-containing organothiourea that acts as an EC 1.14.18.1 (tyrosinase) inhibitor, a diphenolase inhibitor, and a non-competitive inhibitor of the PvdP tyrosinase of Pseudomonas, which inhibits melanogenesis, and is able to be used in genetic taste testing.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 g | $30 | 6-8 weeks | 6-8 weeks | |
| 25 g | $40 | 35 days | 35 days | |
| 1 mL x 10 mM (in DMSO) | $29 | - | In Stock |
| Description | N-Phenylthiourea (Phenylthiocarbamide) is a phenyl ring-containing organothiourea that acts as an EC 1.14.18.1 (tyrosinase) inhibitor, a diphenolase inhibitor, and a non-competitive inhibitor of the PvdP tyrosinase of Pseudomonas, which inhibits melanogenesis, and is able to be used in genetic taste testing. |
| In vitro | N-Phenylthiourea acts as a reversible competitive inhibitor of tyrosinase in DOPA oxidation assays (Ki = 0.21 μM), significantly reducing DOPA-chrome formation[1]. |
| In vivo | In zebrafish embryos, co-treatment with N-Phenylthiourea (100 μM) and HgCl₂ significantly reduced mercury toxicity, with both mortality and hepatic Hg levels decreasing by 60-fold. In contrast, co-treatment with CH₃HgCl increased toxicity, leading to higher mortality and a 2-fold increase in hepatic Hg accumulation. These results indicate that N-Phenylthiourea has opposite modulatory effects on the toxicity of inorganic and organic mercury[2]. |
| Synonyms | Phenylthiourea, Phenylthiocarbamide |
| Molecular Weight | 152.22 |
| Formula | C7H8N2S |
| Cas No. | 103-85-5 |
| Smiles | S=C(N)NC=1C=CC=CC1 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 80 mg/mL (525.56 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 3.3 mg/mL (21.68 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.